First Routine Lipid Testing in Pediatric Patients
The first routine lipid screening for pediatric patients without cardiovascular risk factors should be performed once between the ages of 9 and 11 years, and again between the ages of 17 and 21 years. 1
Universal Screening Recommendations
- For children without cardiovascular risk factors or family history of early cardiovascular disease (CVD), lipid screening should be performed once between ages 9-11 years and again between ages 17-21 years 1
- Initial testing may be done with a nonfasting non-HDL cholesterol level with confirmatory testing with a fasting lipid panel if abnormal 1
- This universal screening approach is recommended by the American College of Cardiology/American Heart Association (ACC/AHA) and is concordant with the National Heart, Lung, and Blood Institute Expert Panel guidelines 1
Earlier Screening for High-Risk Children
- In children with a family history of early CVD (defined as MI, documented angina, or atherosclerosis in parents, siblings, grandparents, aunts, or uncles at <55 years for men, <65 years for women) or significant hypercholesterolemia, lipid screening should be performed as early as age 2 years 1
- Children with obesity or other metabolic risk factors should have lipid screening to detect disorders associated with metabolic syndrome 1
- Children with type 1 diabetes should have initial lipid profile performed soon after diagnosis (once glycemia has improved) if age ≥2 years 1
Rationale for Age-Specific Screening
- Ages 9-11 years are recommended because:
- Ages 17-21 years are recommended as the second screening point after puberty-related changes have stabilized 1
Follow-up Recommendations
- If initial LDL cholesterol is ≤100 mg/dL (2.6 mmol/L), subsequent testing should be performed at 9-11 years of age 1
- If LDL cholesterol values are within accepted risk levels (<100 mg/dL), repeating the lipid profile every 3 years is reasonable 1
- For abnormal results, follow-up should include lifestyle counseling and potential referral to a specialist for severe abnormalities 1
Current Screening Practices
- Despite recommendations, lipid screening remains underutilized in pediatric practice, with only about 9-11% of children aged 9-11 years receiving recommended screening 2
- Among those screened, approximately 30% have abnormal lipid levels, with higher prevalence in children with obesity 2
- Selective screening based only on family history or risk factors misses many children with lipid abnormalities 1, 3
Clinical Implications
- Universal screening helps identify children with genetic dyslipidemias who may not have obvious risk factors 3
- Early identification allows for reverse-cascade screening of family members to detect familial forms of hypercholesterolemia 1
- Nonfasting lipid parameters are similar to fasting ones, making screening more practical in clinical settings 1
- The goal is early identification and intervention to reduce long-term cardiovascular risk 1